No butts about it: UK approves smoking cessation pill
The UK National Institute for Health and Clinical Excellence recently gave a thumbs-up to Champix (varenicline), a twice-daily drug used to help smokers kick the habit. During a 12-week trial almost half of the smokers tested were able to quit with the help of Champix. The prescription drug minimizes cravings and reduces withdrawal symptoms.In Europe alone, over 1.2 million people die each year from smoking-related illness. The World Health Organization predicts smoking/health costs will skyrocket to approximately $500 billion by 2010. My guess is most smokers are fully aware of the health risks their habit creates and the economic drain it places on society, but an addiction is and addiction is an addition. There's no two ways about it -- smoking is a hard habit to break.
Champix has been on the market for a while, but the new approval comes at an appropriate time -- just one month before a UK-wide ban on smoking in public places goes into effect.













